Background: Chemokines are a family of proteins that chemoattract and activate immune cells by interacting with specific receptors on the surface of their targets. We have shown previously that chemokine receptors including the interleukin-8 receptor B (CXCR2) and the Duffy blood group antigen are expressed on subsets of neurons in various regions of the adult central nervous system.
Introduction
Chemokines are a family of proteins that chemoattract and activate immune cells both in vivo and in vitro [1] . They are classified into three major families depending on whether they have an intervening amino acid separating the first two of their four conserved cysteine residues (C-X-C), do not have the intervening residue (C-C) or fail to express one of the amino-terminal cysteines (C). The members of the C-X-C class include interleukin-8 (IL-8) and melanoma growth stimulatory activity (MGSA), while the C-C class includes RANTES, monocyte chemotactic protein-1 (MCP-1) and the macrophage inflammatory proteins (MIP-1␣ and MIP-1␤). At present, the only C class member is lymphotactin.
The chemokines produce their biological effects by interacting with specific receptors on the surface of their target cells [2] . So far, ten different chemokine receptors have been cloned [3] . These receptors are characterized by a heptahelical structure and belong to a superfamily of serpentine receptors. Most, but not all, are coupled to guanine nucleotide binding proteins (G proteins).
Following the finding that specific C-C and C-X-C chemokines can inhibit human immunodeficiency virus 1 (HIV-1) infection [4] [5] [6] , members of the chemokine receptor family were shown to function as coreceptors in combination with the cell-surface marker CD4 for HIV-1 invasion [7] [8] [9] [10] [11] . Different strains of HIV-1 appear to use different chemokine receptors for viral fusion: macrophage-tropic strains of HIV-1 use mainly CCR5 [8] and to a more limited degree CCR3 and CCR2b [9] [10] [11] , whereas the T-cell-tropic strains of HIV-1 use CXCR4 [7] .
HIV infection within the brain may result in a syndrome of profound cognitive, behavioral, and motor impairment termed the AIDS dementia complex (ADC) or HIV-associated dementia complex (HADC) [12] , which occurs in both adult and pediatric AIDS patients. In general, ADC is more common and more severe as the length of HIV infection increases, and is often more severe in children, suggesting that the developing central nervous system (CNS) is highly vulnerable to HIV-1 [13, 14] .
Expression of C-X-C chemokine receptors within the CNS could be important in the pathogenesis of HIV-1 infection in the CNS. We have shown previously that the chemokine receptors CXCR2 and DARC (the Duffy blood group antigen) are expressed on subsets of neurons in various regions of the CNS [15] . This intriguing finding raises several interesting questions. First, are these receptors biologically functional? Second, is there any evidence to suggest that other members of this family of receptors are expressed on CNS neurons and, if so, can any of them function as coreceptors for HIV-1 and function in ADC? Finally, does the expression of chemokine receptors differ between cells of the immature and mature CNS, suggesting a role for the receptors in neuronal development?
To address the question of chemokine receptor function in CNS neurons, we examined the expression of chemokine receptors in cultured human neurons derived from fetal brains and in terminally differentiated hNT cells, which serve as a model for developing human CNS neurons [16, 17] . The hNT neurons are derived from an undifferentiated cell line, NTera 2, after prolonged treatment with retinoic acid. This can yield pure cultures of cells displaying a post-mitotic neuronal phenotype with features of immature human CNS neurons. These features include expression of a number of neuronal proteins including neurofilament proteins, functional glutamate receptors and the enzyme acetylcholinesterase [18] [19] [20] .
In this study, we demonstrate specific chemokine binding to hNT cells, HIV-1 envelope protein competition for chemokine binding, and chemotactic responses that indicate expression of the biologically active chemokine receptors CXCR2, CXCR4, CCR1 and CCR5 in hNT neurons. We also observed CXCR2 expression in cultured neurons from human fetal brains. These observations suggest that there may be functional chemokine receptors on CNS neurons within the developing nervous system and raise intriguing questions concerning the potential role of chemokines in normal neuronal development, neuronal cell function, and the pathogenesis of neurological dysfunction in ADC.
Results

Peptide antibodies directed against CCR1 and CCR5
Antibodies to several of the chemokine receptors that we wished to examine were already available (see Materials and methods), but we lacked antibodies to CCR1 and CCR5. We therefore raised antibodies to these proteins and tested the purified anti-CCR1 and anti-CCR5 polyvalent antisera by indirect immunofluorescence followed by flow cytometry of transfectants expressing the appropriate receptors. As shown in Figure 1 , the polyvalent anti-receptor antibodies (anti-CCR1 and anti-CCR5) bound to the native receptor expressed by these transfectants. This binding was inhibited by the presence of the appropriate amino-terminal peptides. As assessed by fluorescenceactivated cell sorting (FACS) analysis, neither the polyvalent antibody nor the pre-immune serum bound to untransfected cells or to cells expressing CXCR1, CXCR2 or DARC (data not shown). The antibodies were not, however, tested for crossreactivity with CCR2, CCR3 and CCR4. The reactivity of the pre-immune serum with the receptor transfectants was equivalent to the autofluorescence exhibited by the cells (Fig. 1b) .
Immunological detection of chemokine receptors in hNT cells
To test for chemokine receptor expression, precursor NTera 2 cells and differentiated hNT neurons were stained immunohistochemically using antibodies to CXCR2, CXCR4, CCR1, CCR5 and DARC. The hNT cells were plated in four-and eight-well chamber slides and stained as described in Materials and methods. Little specific staining of the precursor NTera 2 cells was observed (data not shown). In contrast, the differentiated hNT neurons showed specific staining with all of the receptor antibodies tested (Fig. 2a-f ), except those against DARC (data not shown). For the positive cells, both cell bodies and some cellular processes were stained. As can be seen in Figure 2 , the undifferentiated NTera 2 cells formed a background of lightly stained cells on which the strongly reactive hNT neurons were superimposed. The perinuclear cytoplasmic staining suggests the presence of intracellular chemokine receptors that have not yet been translocated to the cell surface. The specificity of the chemokine receptor staining was established by demonstrating either that peptides specific for the antibodies (CXCR2 and CCR5) could appropriately block antibody staining (Fig. 2d,f) or that specific staining was not observed with irrelevant monoclonal and polyclonal antibodies (data not shown). The neuronal hNT cells have been reported to be CD4-negative by immunofluorescence and northern blot [21] , and this was confirmed by the lack of staining with CD4-specific antibodies (Fig. 2g) . The neuronal-like nature of the hNT cells was confirmed by demonstrating positive staining with antibodies to neuronal cell adhesion molecule (NCAM) and to neurofilament (Fig. 2h) . The astrocyte-specific marker glial fibrillary acidic protein (GFAP) was never revealed by immunostaining (Fig. 2i) . The exact distribution of these chemokine receptors on the hNT cells could not be determined by immunohistochemistry because the cells grow in small, tightly packed groups (100-200 m in diameter) that are difficult to resolve optically. Confocal microscopy showed that there was receptor staining in small clusters scattered over the cell bodies and proximal processes of the hNT cells, in addition to the intracellular perinuclear staining (data not shown).
Immunological detection of chemokine receptors in human fetal neurons
Earlier work from our laboratory showed that cultures of human neocortex neurons derived from E17 to E22 fetuses are very similar, morphologically, to hNT cells. Initially, having only antibodies to CXCR2 and DARC, we used these antibodies to examine chemokine receptor expression in these cells. Immunohistochemical staining of human fetal neurons demonstrated significant staining of neuronal fibers with a pan neurofilament antibody (Fig. 3a) . Staining with antibodies to CXCR2 revealed a strongly staining cluster of small primitive neurons (Fig. 3b) . Astroglial cells adjacent to a cluster of non-staining neurons stained strongly with antibodies to GFAP (Fig. 3c) . Figure 3d shows a group of neurons that show cytoplasmic staining and staining on their processes with antibodies to CXCR2. A large glial cell in the same field of view shows a slight blush of staining with the same antibody. The Fy6 antibody, specific for DARC, did not stain these cells (data not shown). Irrelevant polyclonal or monoclonal antibodies also failed to stain these cells (Fig. 3e) .
Chemokine receptors in hNT cells bind ligand with high affinity
Given that we have demonstrated the presence of chemokine receptors on hNT neurons, and that these receptors are known to bind and respond to specific ligands [2] , we wished to determine if these cells can bind 125 Ilabeled chemokines and whether this binding can be displaced by an excess of unlabeled ligands. The chemokine receptor CXCR2 binds both IL-8 and MGSA with high affinity [22] , and so we carried out receptor-binding studies with radiolabeled IL-8. Scatchard analysis of competition binding studies with 125 I-labeled IL-8 revealed the presence of a single class of high-affinity binding sites with a receptor density of 4000 sites per cell and a K D of 3.8 ± 0.4 nM (Fig. 4a ). To test for binding to CXCR4, we used stromal cell-derived factor 1 (SDF-1), which was identified recently as a ligand for CXCR4 [6, 21] and found to block the invasion of T-cell-tropic strains of HIV-1, which use CXCR4 as a cofactor [5, 6] . To probe CXCR4 binding sites on hNT cells, we chemically synthesized and radiolabeled SDF-1, and performed receptor-binding studies. Scatchard analysis of competition binding studies with 125 Ilabeled SDF-1 revealed a single class of high-affinity binding sites with a receptor density of 8000 sites per cell and a K D of 54 ± 8.3 nM (Fig. 4b) . Finally, radiolabeled MIP-1␤, a high affinity ligand for CCR5 [23] , was used to characterize this receptor on hNT cells. Scatchard analysis of competition binding studies with 125 I-labeled MIP-1␤ revealed a single class of high affinity binding sites with a receptor density of 3000 sites per cell and a K D of 9.7 ± 1.6 nM (Fig. 4c) . In contrast, no chemokine binding was observed in the undifferentiated NTera 2 cells with Bound/free any chemokine tested (data not shown).
Dose-dependent induction of chemotaxis in hNT neurons
The studies above strongly support the idea that highaffinity chemokine receptors are present on the cell surface of hNT neurons. To determine if these receptors are functionally active, we carried out chemotaxis assays. Chemotaxis of both precursor NTera 2 and neuronal hNT cells were carried out as described in Materials and methods. The hNT neurons demonstrated a potent chemotactic response with increasing concentrations of chemokines. A five-fold to nine-fold increase in chemotaxis was seen, depending on the particular chemokine (Fig. 5a,c) . All of the chemokines tested, apart from platelet factor 4 (PF-4), which was negative, gave a typical bell-shaped curve at concentrations up to 1 g ml -1 (Fig.  5a,c) . Based on these data, chemokine receptors on hNT neurons are biologically functional and can elicit a cellular response to their appropriate ligands. In contrast, as shown in Figure 5b , the precursor cells responded poorly to increasing concentrations of chemokines and demonstrated at best only a two-fold increase in migratory response.
Strain IIIB gp120 envelope protein competes with SDF-1 for binding to CXCR4 As it has been shown that hNT neurons support CD4-independent infection with T-cell-tropic virus [21] and that T-cell-tropic strains of HIV-1 use CXCR4 as a coreceptor for viral fusion [7] , we next examined whether the gp120 envelope protein from the T-cell-tropic virus strain IIIB could block SDF-1 binding to CXCR4. Competition binding studies in which hNT cells were incubated with 125 I-labeled SDF-1 in the presence and absence of increasing concentrations of IIIB envelope protein demonstrated that increasing concentrations of the envelope protein could effectively displace the radiolabeled SDF-1 (Fig. 6a) . Scatchard analysis of the competition binding studies revealed a single class of high affinity binding sites with a receptor density of 6100 sites per cell and a K D of 70 ± 26 nM (Fig. 6a inset) . These data are similar to those obtained when unlabeled SDF-1 was used as the competitor (Fig. 4b) . As the kinetics and doseresponse profiles of displacement for gp120 and SDF-1 were very similar (Figs 4b and 6a) , it is very likely that these molecules are binding to the same receptor on the hNT cells. To investigate this further, 125 I-labeled IIIB gp120 was added to hNT cells and the ability of increasing concentrations of unlabeled SDF-1 to displace the labeled viral protein was assessed. Figure 6b shows the data from a representative series of experiments, which demonstrated (Fig. 6b) . These data were similar to those observed when unlabeled gp120 was used in competition with radiolabeled SDF-1 (Fig. 6a) , demonstrating that the two proteins are competing for binding to one receptor, CXCR4. Radiolabeled binding of IIIB gp120 to these cells was not inhibited by 1 M MIP-1␣ or IL-8, and there was no displaceable binding of IIIB gp120, SDF-1, MIP-1␣, MIP-1␤, IL-8, MGSA or RANTES to the undifferentiated cells (data not shown).
To further establish the specificity of SDF-1 and IIIB gp120 binding to CXCR4, we tested whether an irrelevant viral glycoprotein from herpes simplex virus-1 (gD HSV-1) and a specific monoclonal antibody (12G5) to CXCR4 could block specific binding. As shown in Figure 7 , the gD HSV-1 protein had no effect on either SDF-1 or IIIB gp120 binding to CXCR4. In addition, envelope protein from the HIV-1 T-cell-tropic viral strain BRU inhibited SDF-1 binding to CXCR4. The monoclonal antibody for CXCR4 inhibited both SDF-1 and IIIB gp120 binding in hNT cells (Fig. 7) . It has been suggested previously that galactosylceramide (GalCer) can act as a CD4-independent receptor for HIV-1 [24] , but we were unable to show any effect on either SDF-1 or IIIB binding using a specific antibody to GalCer.
Discussion
Two separate reports recently showed that the orphan receptor LESTR (leukocyte-expressed seven-transmembrane-domain receptor; [25, 26] ) responded to SDF-1 in
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Figure 7
Displacement of (a) 125 I-labeled SDF-1 and (b) 125 I-labeled IIIB gp120 from hNT cells by an irrelevant viral glycoprotein gD HSV-1 and a specific monoclonal antibody (12G5) to CXCR4. The concentration of radiolabeled ligand was 500 pM, and the displacing reagents were at the following concentrations: SDF-1 and IIIB gp120, 1 M; BRU gp120, 330 nM; HSV-1 gD, 1 M; anti-CXCR4 antibody, 500 nM; and anti-GalCer antibody, 300 nM. Ca 2+ -flux assays [5, 6] , and so this receptor was designated CXCR4. Here, we demonstrate that hNT neurons express CXCR4 and other chemokine receptors, including CXCR2, CCR1 and CCR5, and that these receptors bind their appropriate ligands with high affinity (Fig. 2-4 ). This study is the first to report high-affinity binding of SDF-1 to CXCR4 (Fig. 4) . In addition, we show that SDF-1 is able to stimulate chemotaxis of hNT cells, that the magnitude of this stimulation depends on SDF-1 dose, and that half-maximal stimulation occurs with 50 nM ligand (Fig. 5c ) -which is consistent with the reported concentration range for SDF-1-mediated induction of cell migration and actin polymerization in T cells [27] . All of the chemokines that demonstrate high-affinity binding to hNT cells (Fig. 4) are able to stimulate chemotaxis in hNT cells at half-maximal doses consistent with their binding affinities (Fig. 5) . Finally, we show that the gp120 envelope protein from a T-cell-tropic virus can inhibit SDF-1 binding to the chemokine receptor CXCR4 in the absence of CD4 (Figs 6,7) .
Recently, we demonstrated expression of the chemokine receptors CXCR2 and DARC by subsets of neurons and their processes in normal adult human brain [15] . We also showed that CXCR2 was overexpressed in the neuritic portion of Alzheimer's plaques. Based on these data, we postulated that chemokine receptors may function in injury, maintenance or repair in the CNS. It is clear that chemokines are important in inflammation outside the CNS [1] , but the significance of their expression in the CNS is unclear. A number of chemokines, including MIP-1␣, MCP-1, IP-10 and RANTES, have been implicated in inflammation in the CNS [28, 29] . The distribution and morphology of MIP-1␣-immunoreactive cells were identical with those of activated astrocytes. These data suggest that MIP-1␣ may be important in promoting inflammatory and/or repair processes in the brain, possibly by attracting or modulating inflammatory cells. Consistent with this notion, recent studies from Karpus et al. [30] provide strong evidence in support of the concept that this chemokine is a major mediator in the pathogenesis of multiple sclerosis (MS). In this study, antibodies to MIP-1␣ prevented the development of both acute and relapsing paralytic disease in an experimental autoimmune encephalomyelitis (EAE) model of MS in the mouse. Treatment with antibody was also able to ameliorate the severity of ongoing clinical disease.
In addition to the induction of inflammation by chemokines in the CNS, there is also direct experimental evidence supporting the idea that chemokines can modulate normal homeostatic mechanisms in the CNS. The idea that IL-8 functions in the CNS comes from the in situ hybridization of a human IL-8 probe to cells in several regions of the rat brain including the hippocampus and cerebellum [31] . The enhanced survival of rat hippocampal neurons induced by IL-8 in culture assays in vitro [32] offers additional evidence that IL-8 is involved in maintenance of neurons.
Based on our findings that the differentiated NTera 2 cells express the chemokine receptor CXCR4, a recently identified coreceptor for viral fusion [7] , and the report demonstrating that these cells can be infected by the Tcell-tropic HIV-1 strain IIIB [21] , we asked whether we could demonstrate a direct interaction between viral gp120 and CXCR4, in the absence of CD4. The competitive displacement of the CXCR4 radiolabeled ligand SDF-1 by IIIB gp120 protein from two T-cell-tropic strains of HIV-1, and the counter-displacement of radiolabeled IIIB gp120 by SDF-1 is strong evidence for a direct association between the viral glycoprotein and the chemokine receptor CXCR4. Furthermore, this interaction appears to be CD4-independent, consistent with recent findings showing CD4-independent invasion for some strains of HIV-2 [33] . Based on these data, it remains a distinct possibility that the viral infection of differentiated NTera 2 cells could occur via an interaction with the chemokine receptor CXCR4, but to confirm this further work will be required, including viral infectivity assays and specific blocking of infectivity with SDF-1 or monoclonal antibodies to CXCR4.
The expression of functional chemokine receptors on immature CNS-like (hNT) neurons in vitro and the competitive displacement of CXCR4 ligand binding by HIV-1 (strain IIIB) envelope glycoprotein gp120 raise the possibility of neuronal chemokine receptor involvement in HIV-1-induced neuronal cell dysfunction. It has been shown that gp120 is toxic to primary embryonic human and non-human neurons in vitro and in vivo through both direct binding and indirect interactions with glial cells [34] [35] [36] . The toxic effects are probably mediated by NMDA receptors, which could be activated by the release of glutamate by direct or indirect interactions of gp120 with a number of intracellular metabolites [37, 38] .
Our study suggests that direct interactions occur between neuronal chemokine receptors and soluble monomeric gp120 (or virus-associated envelope). It is possible that neurons exposed to HIV could display altered cellular functions or responses to glia. One recent study demonstrated trimolecular co-precipitation of CXCR4, CD4 and gp120 from transfected murine fibroblasts treated with soluble monomeric gp120 [39] . These authors postulated that a direct interaction between gp120, CD4 and CXCR4 on the cell surface is necessary for subsequent viral entry. Our data suggests that gp120 and CXCR4 interact directly on hNT cells in the absence of CD4. Although it is clear that hNT cells can be infected by the IIIB strain of HIV-1 [21] , it is not yet clear whether viral infectivity occurs by interaction with CXCR4. However, as chemokine receptor activation by chemokines induces chemotactic responses as well as Ca 2+ influxes in myeloid cells [40] , similar effects might be expected in immature neurons. Interestingly, Ca 2+ influxes and migration are also observed in embryonic neurons in response to various extracellular stimuli, including exposure to the HIV-1 transactivator protein, Tat [41] . Our observation of chemokine-induced hNT neuronal migration is consistent with the idea that human embryonic neuronal cells use chemokine receptors for chemotaxis, which has not previously been described. Whether such neuronal chemotactic responses occur in the developing human brain is unknown, and whether gp120 expressed in vivo within the developing brain could interfere with neuronal migration is entirely speculative, as abnormalities of neuronal migration in HIV-1-infected fetuses have, to our knowledge, not been described. Nonetheless, the expression of functional chemokine receptors on hNT neurons and interference with ligand binding by gp120 suggest the possibility of secondary responses to chemokines in neurons and modulation of such responses by gp120 in vivo.
Conclusions
Here, we demonstrate that hNT cells express the chemokine receptors CXCR2, CXCR4, CCR1 and CCR5. We also show that these receptors are biologically active and respond physiologically to their ligands. Finally, we show that the gp120 envelope protein from a T-cell-tropic virus can inhibit SDF-1 binding to the chemokine receptor CXCR4 in a CD4-independent manner. As hNT cells are characteristic of human neurons in the CNS and can be readily obtained in large numbers by cell culture, they represent an ideal system for the further examination of the biological functions of chemokine receptors in the CNS.
Materials and methods
Materials
SDF-1 was generated by peptide synthesis, purified by high-performance liquid chromatography and radiolabeled by the IODO-Bead method (Pierce Rockford, Illinois) according to the manufacturer's protocol. The labeled SDF-1 was purified by gel filtration and the initial specific activity was 320-426 Ci mmol -1 . IIIB gp120 was from ICN Pharmaceuticals (Costa Mesa, California). IIIB gp120 was radiolabeled and purified using the method described for SDF-1, and had a specific activity of 210 Ci mmol -1 . 125 I-labeled IL-8 and MIP-1␤ (specific activity 2200 Ci mmol -1 ) were from NEN. Unlabeled MIP-1␣, MIP-1␤, MCP-1, PF-4 and RANTES were from Peprotech (Rocky Hill, New Jersey); IL-8 and MGSA were purified as previously described [42, 43] . BRU gp120 was from Biosource (Camarillo, California). Herpes simplex virus type 1 glycoprotein D was isolated as described [44] , as was a monoclonal antibody to galactosylceramide (GalCer) [45] . The CXCR2 antibody was from Santa Cruz Biotechnology (Santa Cruz, California). The CXCR4 monoclonal antibody 12G5 was from James Hoxie [33] . The Fy6 monoclonal antibody to the Duffy blood group antigen (DARC) was isolated as described [46] . Polyclonal antisera to CCR1 and CCR5 were raised in New Zealand white rabbits by subcutaneous and intramuscular injection with the amino-terminal domains of either CCR1 conjugated to KLH or CCR5 conjugated to GST. Following primary immunization and six challenges with peptide, CCR1 antiserum from several pooled bleeds was collected and purified over a Pharmacia 5 ml protein-A sepharose Hi-Trap column (Upsala, Sweden). Following initial immunization with CCR5-conjugated peptide and three challenges with the antigen, aliquots of anti-CCR5 serum were absorbed with glutathione S-transferase (GST)-sepharose to remove antibodies to the GST moiety of the fusion protein. The absorbed antiserum was used to probe western blots containing GST, CCR5-GST, and the CCR5 peptide released from the fusion protein by thrombin cleavage. Purified antibody was analyzed for binding to human kidney 293 cells transfected with CCR1 and CCR5 by indirect immunofluorescence followed by a FACScan. The CD4 antibody, MT310, was from DAKO (Carpinteria, California).
Cell culture
Human fetal brain (E17 to E22 weeks) was obtained from Advanced Bioscience Resources (Alameda, California). Hippocampal regions were removed under sterile conditions within 2-4 h after fetal demise.
The tissue was placed in 20 ml of Isocoves modified Dulbecco's medium (IMDM) and disaggregated by repeated pipetting and then filtration through a metal mesh. Cells were pelleted by centrifugation and grown in IMDM with 10 % fetal bovine serum (FBS), 2 mM L-glutamine and 0.5 mg ml -1 gentamicin. Cells were plated at 1 × 10 6 cells ml -1 in eight-well plastic chamber slides and grown for 1-2 weeks at 37°C in a 5 % CO 2 incubator. Media was replaced every 2 days and the suspension of microglia removed. Prior to fixation, the media and cell suspension were removed, with the majority of the remaining cells being neurons and astrocytes. NTera 2 cells derived from a human embryonic carcinoma cell line (Ntera 2, clone D1) were obtained from Stratagene In addition, some cells were plated onto Matrigel (Collaborative Research) as described [16, 17] . Some cells were plated into four-or eight-well plastic chamber slides for immunohistochemical analysis. hNT cells were shown to be neuronallike based upon expression of neurofilament and microtubule-associated protein antigen by indirect immunofluorescence labeling. Human kidney embryonic 293 cells and CHO cells were cultured according to ATCC recommendations.
Indirect antibody labeling FACS method
Human kidney 293 cells or CHO cells were transfected with the plasmids that encode specific chemokine receptors (CCR1, CCR5, CXCR2 or CXCR4) producing stable cell lines. CCR1 or CCR5 polyclonal antisera was incubated with cells expressing the corresponding receptors (sera and cells were diluted 1:500 in Dulbecco's phosphatebuffered saline (DPBS) with 0.5 % BSA but without Ca 2+ and Mg 2+ ). Cells were placed on ice for 30-60 min. After the cells were pelleted, the supernatant was removed and the cells placed back in DPBS and washed twice. Cells were then incubated with FITC conjugated goat anti-rabbit antibody (diluted 1:5000 in DPBS) on ice in the dark for 30 min. Cells were pelleted and washed as above. Controls for indirect labeling contained no primary antibody, pre-immune serum with secondary antibody, both antibodies but with non-transfected cells, or both antibodies but with the addition of an amino-terminal peptide.
Immunohistochemistry
Cultured cells were grown on either four-or eight-well, plastic (Thermanox™) chamber slides. Live cells were rinsed in phosphate-buffered saline (PBS) and then fixed in situ with 4 % paraformaldehyde, 3 % sucrose in PBS, pH 7.3. After 1 h the fixative was removed and the cells were carefully washed twice in PBS and then stored in PBS at 4°C until the time of staining. Before staining, the cells were blocked for 30 min in PBS containing 0.005 % Triton X-100 and 10 % serum from either goat or donkey (depending on the species of the secondary antibody). The blocking solution was removed and the primary antibodies (diluted in the same buffer used for blocking) were added without a rinse step. After a 1 h incubation at room temperature, the primary antibodies were removed, the tissues were rinsed in PBS, and the staining was completed using a peroxidase-linked (BioGenex) avidin-biotin staining kit appropriate to the species of the primary antibody. The reaction was visualized with diaminobenzidine as chromogen and the cells were lightly counter-stained with hematoxylin to increase nuclear definition. Cells grown on plastic were air-dried and then mounted with glass coverslips using Gelmount™ (Sigma). Cells were viewed on a Zeiss Axioskop and photographed with an attached Fuji HC-2000, three-chip CCD digital camera. Images were first edited in Adobe Photoshop 3.0 to enhance contrast and white balance and then printed on a Fuji Pictrography 3000 digital printer.
Chemokine binding studies
hNT cells in 16-well, plastic (Thermanox™) chamber slides were incubated in PBS with radiolabeled chemokines (500 pM) in the presence and absence of increasing concentrations of unlabeled chemokines at room temperature for 30 min. In addition, HIV-1 IIIB gp120 (ICN) was used to displace 125 I-labeled SDF-1. The incubation was terminated by gentle aspiration of the supernatant. The cells were washed once in PBS and solubilized by the addition of 100 l of 25 % SDS, and transferred to vials for counting in a gamma counter. Nonspecific binding was determined in the presence of 1 M unlabeled chemokines. Each chemokine or gp120 protein concentration was tested in duplicate.
The binding data were curve-fitted with the computer program IGOR (Wavemetrics) to determine the affinity (K D ), number of sites and amount of non-specific binding.
Chemotaxis
Differentiated and non-differentiated NTera 2 cell migration was examined using a 48-well microchemotaxis assay as previously described [47] . Briefly, various concentrations of chemokine were placed in the lower wells of a 48-well microchemotaxis chamber. Human NTera 2 and hNT cells (2-5 × 10 6 cells ml -1 ) were then placed in the upper compartment of the chamber. The upper and lower wells of the chamber were separated by a 5 m polycarbonate filter coated with laminin (Sigma, St. Louis, Missouri), which seems to be optimal for human neural cell migration in vitro. The chambers were incubated for 4 h at 37°C (a time period over which chemokine equilibrium between the upper and lower chambers is optimally achieved) after which the filters were scraped, washed, fixed with methanol and stained with DiffQuik. Cell migration was measured by counting the number of cells attached to the lower surface of the filter in five high-power fields. Each concentration of chemokine was tested in either triplicate or sets of six wells. The results were expressed as the number of migrating cells per five high-power fields (± SE).
